About Forentis Partners
Forentis Fund is a precisely focused venture fund raising $50 million for the sole purpose of reducing drug costs worldwide through the advancement of companion diagnostics, and by accelerating new medical advances via biomarker discovery. This will lead to increased effectiveness for pharmaceutical drug development, improved return on investment, and lower healthcare costs. Forentis Fund intends to finance companies focused on the utilization of biomarkers in drug development. Using companion biomarkers yields safer and more efficacious drug products, reduces clinical trial and development costs, improves post-marketing safety profiles and salvages therapies that otherwise would not be granted approval.